Purdue Pharma Assigned Patent for Treating Opioid-Induced Adverse Pharmacodynamic Response

Press/Media

Period30 Dec 2017 → 24 Jan 2018

Media coverage

4

Media coverage

  • TitlePurdue Pharma Assigned Patent for Treating Opioid-Induced Adverse Pharmacodynamic Response
    Media name/outletTargeted News Service
    CountryUnited States
    Date24/01/18
    PersonsDon Kyle
  • TitlePurdue Pharma Assigned Patent for Treating Opioid-Induced Adverse Pharmacodynamic Response
    Media name/outletTargeted News Service
    CountryUnited States
    Date17/01/18
    PersonsDon Kyle
  • TitlePurdue Pharma Assigned Patent for Treating Opioid-Induced Adverse Pharmacodynamic Response
    Media name/outletPharmacy Choice
    CountryUnited States
    Date30/12/17
    URLwww.pharmacychoice.com/news/article.cfm?Article_ID=1914990
    PersonsDon Kyle
  • TitlePurdue Pharma Assigned Patent for Treating Opioid-Induced Adverse Pharmacodynamic Response
    Media name/outletTargeted News Service
    CountryUnited States
    Date30/12/17
    PersonsDon Kyle